Lifetime risk estimators in epidemiological studies of Krabbe Disease-Reference-Cited by-同舟云学术

Lifetime risk estimators in epidemiological studies of Krabbe Disease

Published:2013-01 Issue:1 Volume:1 Page:e25212
ISSN:2167-5511
Container-title:Rare Diseases
language:en
Short-container-title:Rare Diseases

Author:

Foss Alexander H.,Duffner Patricia K.,Carter Randy L.

Publisher

Informa UK Limited

Subject

General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.4161/rdis.25212

Reference46 articles.

1. Inborn Lysosomal Diseases

2. Inherited Disorders of Lysosomal Metabolism

3. Structure and organization of the human galactocerebrosidase (GALC) gene

4. Wenger DA. Krabbe Disease (Globoid Cell Leukodystrophy). In: Raymond GV, Eichler F, Fatemi A, Naidu S, eds. Leukodystrophies. London: Mac Keith Press; 2011.

5. Newborn Screening for Krabbe Disease: the New York State Model

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Terra incognita of glial cell dynamics in the etiology of leukodystrophies: Broadening disease and therapeutic perspectives;Life Sciences;2024-10

2. A systematic review on the birth prevalence of metachromatic leukodystrophy;Orphanet Journal of Rare Diseases;2024-02-21

3. Krabbe Disease–To Add or Not to Newborn Screening?;OBM Genetics;2024-01-12

4. Systematic literature review of the epidemiology of glycogen storage disease type 1a;Journal of Pediatric Endocrinology and Metabolism;2023-08-25

5. A Roadmap for Potential Improvement of Newborn Screening for Inherited Metabolic Diseases Following Recent Developments and Successful Applications of Bivariate Normal Limits for Pre-Symptomatic Detection of MPS I, Pompe Disease, and Krabbe Disease;International Journal of Neonatal Screening;2022-11-15